| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/12/2007 | US20070082858 Methods and compositions for the prevention of toxic side effects of aminoglycoside medications |
| 04/12/2007 | US20070082857 combination of an aminoglycoside antibiotic such as tobramycin or gentamicin, bromfenac as a nonsteroidal antiinflammatory agent and nicotinamide; an eye drop, nose drop or an injection; no side effects; no precipitation even after preservation |
| 04/12/2007 | US20070082856 Combination therapy comprising the use of et-743 and doxorubicin for treating cancer |
| 04/12/2007 | US20070082855 Pharmaceutical formulations employing short-chain sphingolipids and their use |
| 04/12/2007 | US20070082854 Novel polymorphs of erythromycin compound |
| 04/12/2007 | US20070082853 6, 11-bridged tricyclic macrolides |
| 04/12/2007 | US20070082852 Wound and skin care products |
| 04/12/2007 | US20070082851 Treatment of a condition in a mammal with administration of Compounds and Methods of Use |
| 04/12/2007 | US20070082850 Derivatives of mannose-6-phosphate that are resistant to phosphatase and mannosidase enzymes; for treatment of disease or condition wherein T lymphocyte migration from blood to tissue or other extravascular site is step in development of the disease or condition; 1-methyl-2,3,4,6-tetrabenzyl-mannoside |
| 04/12/2007 | US20070082846 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 04/12/2007 | US20070082845 Ferritin as a therapeutic target in abnormal cells |
| 04/12/2007 | US20070082841 Ocular administration of immunosuppressive agents |
| 04/12/2007 | US20070082840 Combination therapy for inhibition of platelet aggregation |
| 04/12/2007 | US20070082838 Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| 04/12/2007 | US20070082384 Process for the Heterotrophic Production of Microbial Products with High Concentrations of Omega-3 Highly Unsaturated Fatty Acids |
| 04/12/2007 | US20070082375 Topically administering to a nail of subject having onychomycosis a therapeutically effective amount of an antifungal compound such as (2R, 3R)-2-(2,4-difluorophenyl)-3-(4-methylen piperidine-1-yl)-1-(1H-1,2,4-triazole-1-yl)butane-2-ol |
| 04/12/2007 | US20070082374 Method of treating a condition associated with phosphorylation of task-1 |
| 04/12/2007 | US20070082373 Processes for regulating blood glucose in a mammal and novel polypeptides useful in NAD biosynthesis |
| 04/12/2007 | US20070082077 Inhibitor of glucose absorption and method for producing the same |
| 04/12/2007 | US20070082073 Catechin Adjuvants |
| 04/12/2007 | US20070082070 Treating skin disorders |
| 04/12/2007 | US20070082068 Il-8 production promoters and use thereof |
| 04/12/2007 | US20070082067 2-[4-(3-Methoxy-4-pyridin-2-ylphenyl)-2H-1,2,3-triazol-2-yl]pyridine; psychiatric and mood disorders, schizophrenia, anxiety, depression, panic, and bipolar disorder, as well as in the treatment of pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders |
| 04/12/2007 | US20070082066 Use of zeaxanthin to reduce light hyper-sensitivity, photophobia, and medical conditions relating to light hyper-sensitivity |
| 04/12/2007 | US20070082065 Therapeutic composition for the treatment of dry eye syndrome |
| 04/12/2007 | US20070082064 Nutritional or dietary supplement for the treatment of macular degeneration |
| 04/12/2007 | US20070082063 Risk assessment and correction of membrane damage of the upper GI tract |
| 04/12/2007 | US20070082062 Calcium phosphate-based materials containing zinc, magnesium, fluoride and carbonate |
| 04/12/2007 | US20070082061 Reduction of saltiness with sweeteners |
| 04/12/2007 | US20070082055 Stable micronized candesartan cilexetil and methods for preparing thereof |
| 04/12/2007 | US20070082053 Solid dispersions of opioid antagonists |
| 04/12/2007 | US20070082051 Modified Release Formulations of Antihypertensive Drugs |
| 04/12/2007 | US20070082049 Extended release venlafaxine tablet formulation |
| 04/12/2007 | US20070082048 Sleep aid formulations |
| 04/12/2007 | US20070082047 Solid preparation |
| 04/12/2007 | US20070082046 Enteric valproic acid |
| 04/12/2007 | US20070082044 Synergistic effect of compositions comprising carotenoids selected from lutein, beta-carotene and lycopene |
| 04/12/2007 | US20070082041 Topical delivery of codrugs |
| 04/12/2007 | US20070082040 Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides |
| 04/12/2007 | US20070082039 Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids, the use of the same as percutaneous permeation enhancers, and topical gels for the transdermal delivery of steroids |
| 04/12/2007 | US20070082038 Transdermal nicotine salt delivery system |
| 04/12/2007 | US20070082037 Transdermal preparations and method for relieving side effects in pergolide therapy |
| 04/12/2007 | US20070082035 Anti-infective hygiene products based on cellulose acetate phthalate |
| 04/12/2007 | US20070082031 L-lysine-containing feed additives |
| 04/12/2007 | US20070082024 Tyrosinase activity inhibitor and ameliorant for facial blood flow |
| 04/12/2007 | US20070082022 Latent reactive blood compatible agents |
| 04/12/2007 | US20070082017 Lipid compositions and methods of use |
| 04/12/2007 | US20070082016 Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amide renin inhibitor in absorption enhancing carrier comprising lipophilic component, high HLB surfactant, hydrophilic component, which on mixing forms stable microemulsion concentrate; bioavailability; side effect reduction; cardiovascular disorders |
| 04/12/2007 | US20070081974 Antibody targeting osteoclast-associated protein |
| 04/12/2007 | US20070081967 Revitalizing hair follicles with total parenteral nutrition or hyperalimentation for maximum hair growth |
| 04/12/2007 | US20070081962 Novel delivery of immune response modifiers for removal of chronic tattoos |
| 04/12/2007 | US20070081948 Dry powder composition comprising a benzodiazepine for pulmonary inhalation |
| 04/12/2007 | US20070081942 Gene differentially expressed in breast and bladder cancer, and encoded polypeptides |
| 04/12/2007 | US20070081941 F-18 Labeled Amino Acid Analogs |
| 04/12/2007 | DE102005049001A1 Verfahren zur Herstellung von direkttablettierbaren Ibuprofen-Formulierungen A process for the production of direct-tabletable ibuprofen formulations |
| 04/12/2007 | DE102005048824A1 Behandlung und Prophylaxe von Mikroangiopathien Treatment and prevention of microangiopathy |
| 04/12/2007 | DE102005048293A1 Retardformulierung für Pralnacasan Sustained-release formulation pralnacasan |
| 04/12/2007 | CA2823159A1 Polymorphic form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide |
| 04/12/2007 | CA2665370A1 Odcase inhibitors for the treatment of malaria |
| 04/12/2007 | CA2625447A1 Compositions and methods for stimulating gastrointestinal motility |
| 04/12/2007 | CA2625340A1 Pharmaceutical composition for treatment or prevention of nephritis and method for producing same |
| 04/12/2007 | CA2624933A1 Methods for treating respiratory disorders |
| 04/12/2007 | CA2624882A1 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/12/2007 | CA2624879A1 Imidazopyridine derivatives as a2b adenosine receptor antagonists |
| 04/12/2007 | CA2624875A1 New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease |
| 04/12/2007 | CA2624869A1 New compounds ii |
| 04/12/2007 | CA2624795A1 Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as d-amino acid oxidase inhibitors |
| 04/12/2007 | CA2624731A1 Hydrogenated pyrido-indole compounds for the treatment of huntington's disease |
| 04/12/2007 | CA2624726A1 4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | CA2624716A1 Use of soluble guanylate cyclase activators for treating acute and chronic lung diseases |
| 04/12/2007 | CA2624699A1 Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists |
| 04/12/2007 | CA2624681A1 N-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | CA2624649A1 Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders |
| 04/12/2007 | CA2624568A1 Oligouronate treatment |
| 04/12/2007 | CA2624533A1 Phosphoantigen salts of organic bases and methods for their crystallization |
| 04/12/2007 | CA2624524A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2007 | CA2624513A1 Combination |
| 04/12/2007 | CA2624501A1 Antibacterial pyrrols |
| 04/12/2007 | CA2624495A1 Preparation and use of tetrahydropyrrolo [3, 2-c] pyridin-4-one derivatives for treatment of obesity, psychiatric and neurological disorders |
| 04/12/2007 | CA2624493A1 Pharmaceutically active tetrahydro-pyrrolo[1,2-b]isothiazole 1,1-dioxides |
| 04/12/2007 | CA2624488A1 Tetrahydro-pyrrolizinone compounds as lfa-i mediators |
| 04/12/2007 | CA2624468A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 04/12/2007 | CA2624463A1 Novel parenteral carbamazepine formulation |
| 04/12/2007 | CA2624450A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2007 | CA2624449A1 Use of neboglamine in the treatment of toxicodependency |
| 04/12/2007 | CA2624413A1 Naphthyridin derivatives |
| 04/12/2007 | CA2624378A1 Macroheterocylic compounds as kinase inhibitors |
| 04/12/2007 | CA2624357A1 Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | CA2624354A1 Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | CA2624345A1 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | CA2624343A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
| 04/12/2007 | CA2624326A1 Cyclic n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | CA2624323A1 Combination therapy comprising substituted oxazolidinones for the prevention and treatment of cerebral circulatory disorders |
| 04/12/2007 | CA2624310A1 Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide |
| 04/12/2007 | CA2624306A1 Solid pharmaceutical dosage forms which can be adminstered orally and have rapid release of active ingredient |
| 04/12/2007 | CA2624294A1 Substituted quinolines as inhibitors of leukotriene biosynthesis |
| 04/12/2007 | CA2624253A1 2-amino-7,8-dihydro-6h-pyrido[4,3-d] pyrimidin-5-ones |
| 04/12/2007 | CA2624228A1 Biomedical bond enhancer |
| 04/12/2007 | CA2624220A1 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 04/12/2007 | CA2624179A1 Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties |